ClinicalTrials.gov record
Completed Phase 3 Interventional

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

ClinicalTrials.gov ID: NCT05586958

Public ClinicalTrials.gov record NCT05586958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-regional, Double-blind, Parallel-group, Placebo-controlled Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment With Tigulixostat in Gout Patients With Hyperuricemia

Study identification

NCT ID
NCT05586958
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
LG Chem
Industry
Enrollment
354 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Tigulixostat Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2022
Primary completion
Nov 3, 2024
Completion
Dec 15, 2024
Last update posted
Oct 28, 2025

2022 – 2024

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Medvin Clinical Research Covina California 91722
Clinical Research of West Florida, Inc. Clearwater Florida 33765
Herco Medical and Research Center, Inc Coral Gables Florida 33134
Direct Helpers Research Center Hialeah Florida 33012
Allied Biomedical Research Institute Miami Florida 33155
Research Institute of South Florida, Inc. Miami Florida 33173
Clinical Research of West Florida, Inc. Tampa Florida 33606
Conquest Research, LLC Winter Park Florida 32789
Vista Clinical Research, LLC Newnan Georgia 30265
Velocity Clinical Research Meridian Idaho 83642
Healthcare Research Network II, LLC Flossmoor Illinois 60422
Alliance for Multispecialty Research, LLC Lexington Kentucky 40509
L-MARC Research Center Louisville Kentucky 40213
MD Medical Research Oxon Hill Maryland 20745
Elite Clinical Research, LLC Jackson Mississippi 39202
Olive Branch Family Medical Center Olive Branch Mississippi 38654
Practice Dr. David Headley Port Gibson Mississippi 39150
HealthCare Research Hazelwood Missouri 63042
Healor Primary Care/CCT Research Las Vegas Nevada 89102
Meridian Clinical Research, LLC Vestal New York 13850
Triad Clinical Trials Greensboro North Carolina 27410
STAT Research Vandalia Ohio 45377
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Tristar Clinical Investigations, P.C. Philadelphia Pennsylvania 19114
Velocity Clinical Research Greenville Greenville South Carolina 29615
PCCR Solutions Colleyville Texas 76034
Pioneer Research Solutions, Inc. Houston Texas 77099
Endeavor Clinical Trials San Antonio Texas 78240
DM Clinical Research Tomball Texas 77377
Highland Clinical Research Salt Lake City Utah 84124
South Ogden Family Medicine/CCT Research South Ogden Utah 84405
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Meridian Clinical Research, LLC Portsmouth Virginia 23703
Dominion Medical Associates, Inc. Richmond Virginia 23219
Clinical Research Partners, LLC Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05586958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05586958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →